BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sarvizadeh M, Hasanpour O, Naderi Ghale-Noie Z, Mollazadeh S, Rezaei M, Pourghadamyari H, Masoud Khooy M, Aschner M, Khan H, Rezaei N, Shojaie L, Mirzaei H. Allicin and Digestive System Cancers: From Chemical Structure to Its Therapeutic Opportunities. Front Oncol 2021;11:650256. [PMID: 33987085 DOI: 10.3389/fonc.2021.650256] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Qian Y, Su H, Ge Y, Lei K, Li Y, Fan H. Prognostic value of PD-L1 expression combined with hypoxia-associated immunosuppression in hepatocellular carcinoma. Biomark Med 2022. [PMID: 35212229 DOI: 10.2217/bmm-2021-1051] [Reference Citation Analysis]
2 He RQ, Li JD, Du XF, Dang YW, Yang LJ, Huang ZG, Liu LM, Liao LF, Yang H, Chen G. LPCAT1 overexpression promotes the progression of hepatocellular carcinoma. Cancer Cell Int 2021;21:442. [PMID: 34419067 DOI: 10.1186/s12935-021-02130-4] [Reference Citation Analysis]
3 Duan X, Yu X, Li Z. Circular RNA hsa_circ_0001658 regulates apoptosis and autophagy in gastric cancer through microRNA-182/Ras-related protein Rab-10 signaling axis. Bioengineered 2022;13:2387-97. [PMID: 35030981 DOI: 10.1080/21655979.2021.2024637] [Reference Citation Analysis]
4 Hong S, Yan Z, Song Y, Bi M, Li S. Down-regulation of lncRNA FEZF1-AS1 mediates regulatory T cell differentiation and further blocks immune escape in colon cancer. Expert Rev Mol Diagn 2021. [PMID: 34877908 DOI: 10.1080/14737159.2022.2012157] [Reference Citation Analysis]
5 Catanzaro E, Canistro D, Pellicioni V, Vivarelli F, Fimognari C. Anticancer potential of allicin: A review. Pharmacological Research 2022. [DOI: 10.1016/j.phrs.2022.106118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Wang Y, Zhang X, Dai X, He D. Applying immune-related lncRNA pairs to construct a prognostic signature and predict the immune landscape of stomach adenocarcinoma. Expert Rev Anticancer Ther 2021;:1-10. [PMID: 34319826 DOI: 10.1080/14737140.2021.1962297] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Zheng H, Liu H, Ge Y, Wang X. Integrated single-cell and bulk RNA sequencing analysis identifies a cancer associated fibroblast-related signature for predicting prognosis and therapeutic responses in colorectal cancer. Cancer Cell Int 2021;21:552. [PMID: 34670584 DOI: 10.1186/s12935-021-02252-9] [Reference Citation Analysis]
8 Zhou Y, Li X, Luo W, Zhu J, Zhao J, Wang M, Sang L, Chang B, Wang B. Allicin in Digestive System Cancer: From Biological Effects to Clinical Treatment. Front Pharmacol 2022;13:903259. [DOI: 10.3389/fphar.2022.903259] [Reference Citation Analysis]
9 Nadeem MS, Kazmi I, Ullah I, Muhammad K, Anwar F. Allicin, an Antioxidant and Neuroprotective Agent, Ameliorates Cognitive Impairment. Antioxidants 2022;11:87. [DOI: 10.3390/antiox11010087] [Reference Citation Analysis]
10 He W, Wang B, He J, Zhao Y, Zhao W. SSR4 as a prognostic biomarker and related with immune infiltration cells in colon adenocarcinoma. Expert Rev Mol Diagn 2021;:1-9. [PMID: 34904499 DOI: 10.1080/14737159.2022.2019015] [Reference Citation Analysis]
11 Zhang X, Lu N, Wang L, Wang Y, Li M, Zhou Y, Cui M, Zhang M, Zhang L. Recent advances of m6A methylation modification in esophageal squamous cell carcinoma. Cancer Cell Int 2021;21:421. [PMID: 34376206 DOI: 10.1186/s12935-021-02132-2] [Reference Citation Analysis]